Quick Answer
Pharma-Bio Serv, Inc. reported Diluted EPS of $0.00 per share (loss) for fiscal year 2025.
Pharma-Bio Serv, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.00 | +88.2% |
| 2024 | -$0.03 | -159.6% |
| 2023 | $0.06 | +193.4% |
| 2017 | -$0.06 | -454.5% |
| 2016 | -$0.01 | -115.9% |
| 2015 | $0.07 | -32.4% |
| 2014 | $0.10 | -50.7% |
| 2013 | $0.21 | +1.5% |
| 2012 | $0.20 | +45.7% |
| 2011 | $0.14 | +723.5% |
| 2010 | $0.02 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $0.00 | — | -88.9% |
| July 31, 2025 | $0.01 | -35.7% | +125.0% |
| April 30, 2025 | $0.00 | +144.4% | — |
| January 31, 2025 | $0.00 | +100.0% | -100.0% |
| July 31, 2024 | $0.01 | — | +255.6% |
| April 30, 2024 | -$0.01 | — | +25.0% |
| January 31, 2024 | -$0.01 | — | -137.5% |
| July 31, 2018 | $0.03 | +557.1% | +633.3% |
- Pharma-Bio Serv, Inc. showed an increase of +88.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2025 period, Pharma-Bio Serv, Inc.’s diluted eps has declined by 123.5% (from $0.02 per share to $0.00 per share (loss)).
- The most recent figure is from Pharma-Bio Serv, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: